Skip to content

WheelRight tyre monitoring adopted by US ‘highway of the future’

Oxford-based WheelRight’s tyre monitoring technology is being used as part of a US ‘highway of the future’ project. 21 December 2016, Transport Engineer. The live project covers an 18-mile stretch – dubbed ‘The Ray’ – on interstate 85 from Georgia to Alabama, and aims to demonstrate how US interstates can eliminate deaths, waste and carbon. … Continued

InspireSport record month for bookings

Calculus Capital’s portfolio company InspireSport have recorded a record-breaking month for tour bookings. Steve Butchart, CEO, InspireSport: “It’s been a record breaking two months for inspiresport. November was the biggest single booking month for the company since its formation in 2004, while October represented the largest single month for volume of tours departing. These two … Continued

Calculus Capital invests £3m in Jumptastic

London, 15 December 2016: Private equity fund manager and Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £3m in UK trampoline park company Jumptastic as it plans to expand into Scandinavia. Jumptastic’s highly successful first park opened in Gloucester in 2015, offering 90 interlinked trampolines over 30,000 square feet. The … Continued

Synpromics announces expansion of research collaboration with Adverum Biotechnologies

Calculus Capital’s portfolio company Synpromics, the leading synthetic promoter and gene control company, has announced the expansion of the research collaboration with Adverum Biotechnologies that began in December 2015. The initial collaboration focused on using Synpromics technology to develop promoters for the treatment of eye diseases, and has yielded promising early results. The new research … Continued

VCTs slash fundraising levels

John Glencross, CEO of Calculus Capital is cited in the FT’s latest VCT article. Investors face missing out on lucrative tax breaks as popular venture capital trusts cut yearly fundraising levels, warn wealth managers. Jason Hollands, managing director at Tilney Bestinvest, said there was an ongoing “supply crunch” around the funds, which offer investors 30 … Continued

Venn Life Sciences wins new contract worth EUR2.5m

Venn Life Sciences has signed a new contract worth €2.5m with Sedana Medical for a phase III trial. The trial, which is confined to patients in Germany and commences immediately, will confirm the efficacy and safety of sedation with isoflurane in ventilated intensive care patients. Sedana Medical is based in Sweden with operations across Europe, … Continued

Online technology provider Quai Administration wins new contract with Punter Southall Aspire

Punter Southall Aspire appoints online technology provider Quai as administrator for its forthcoming master trust Punter Southall Aspire has selected Quai Administration Services as the out-sourced investment administrator for its forthcoming Master Trust. The firm has also made a strategic investment in Quai, as it continues its approach of taking stakes in service provider partners, … Continued